Haemophilus influenzae is one of the main bacteria responsible for otitis media (OM) among children worldwide. We aimed to estimate the distribution of encapsulated and non-capsulated variants (NTHi), biotypes, antibiotic susceptibility, and molecular epidemiology of H. influenzae isolates recovered from pediatric OM cases in Bulgaria.
Capsule detection was done by PCR for bexB gene, absent in NTHi. All encapsulated strains were subjected to PCR serotyping. MIC susceptibility testing was performed according to the criteria of EUCAST. MLST was conducted for all 71 OM isolates.
The capsule detection and PCR – serotyping disclosed a predominance of NTHi (90.1%) and a few “a”, “f”, and “c” types. Biotype I was the most widespread (42.3%). β-lactam resistance was found in 35.2% of the isolates. MLST represented heterogenic population structure, whereas the most represented clonal complexes belonged to ST-3, ST-57, ST-105, and ST-1426. 42.3% of the STs showed relatedness to globally represented clones, and 11.3% displayed affiliation to international type 2.
Most of the H. influenzae isolates recovered from children with otitis media were non-typable strains from biotype I. The examined population structure was genetically diverse, with a predominance of international type 2 isolates.
Morgan S, Yoder-Himes D, Jackson D, Naber J, Berry R, Cash E, et al. Bactericidal effects of high-energy visible light on common otitis media pathogens. J Appl Microbiol 2022; 3: 1856–65. https://doi.org/10.1111/jam.15366.
Cunningham M, Guardiani E, Kim H, Brook I. Otitis media. Future Microbiol 2012; 6: 733–53. https://doi.org/10.2217/fmb.12.38.2.
Kroll S, Loynds B, Brophy L, Moxon ER. The bex locus in encapsulated Haemophilus influenzae: a chromosomal region involved in capsule polysaccharide export. Mol Microbiol 1990; 4: 1853–62. https://doi.org/10.1111/j.1365-2958.1990.tb02034.x.
Slack M, Esposito S, Haas H, Mihalyi A, Nissen M, Mukherjee P, et al. Haemophilus influenzae type b disease in the era of conjugate vaccines: critical factors for successful eradication. Expert Rev Vaccin 2020; 10: 903–17. https://doi.org/10.1080/14760584.2020.1825948.
Reilly AS, McElligott M, Mac Dermott Casement C, Drew R. Haemophilus influenzae type f in the post-Haemophilus influenzae type b vaccination era: a systematic review. J Med Microbiol 2022; 71(10). https://doi.org/10.1099/jmm.0.001606.
Bakaletz LO, Novotny LA. Nontypeable Haemophilus influenzae (NTHi). Trends Microbiol 2018; 8: 727–8. https://doi.org/10.1016/j.tim.2018.05.001.
Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev, 2007; 2: 368–89. https://doi.org/10.1128/CMR.00040-06.
Khurana P, Shenoy S. Occurrence of blaTEM and blaROB in Haemophilus species causing respiratory tract infections. Infect Disord Drug Targets 2020; 3: 385–388. https://doi.org/10.2174/1871526519666190118103148.
Straker K, Wootton M, Simm A, Bennett PM, MacGowan AP, Walsh TR, et al. Cefuroxime resistance in non-beta-lactamase Haemophilus influenzae is linked to mutations in ftsI. J Antimicrob Chemother 2003; 51: 523–530 https://doi.org/10.1093/jac/dkg107.
Harper JJ, Tilse MH. Biotypes of Haemophilus influenzae that are associated with noninvasive infections. J Clin Microbiol. 1991; 11: 2539–42. https://doi.org/10.1128/jcm.29.11.2539-2542.1991.
Davis GS, Sandstedt SA, Patel M, Marrs CF, Gilsdorf JR. Use of bexB to detect the capsule locus in Haemophilus influenzae. J Clin Microbiol 2011; 7: 2594–601 https://doi.org/10.1128/JCM.02509-10.
Falla TJ, Crook D, Brophy L, Maskell D, Kroll JS, Moxon ER. PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol. 1994; 32: 2382–6. https://doi.org/10.1128/jcm.32.10.2382-2386.1994.
Hasegawa K, Yamamoto K, Chiba N, Kobayashi R, Nagai K, Jacobs MR, et al. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb Drug Resist 2003; 9: 39–46. https://doi.org/10.1089/107662903764736337.
Harmes KM, Blackwood RA, Burrows HL, Cooke JM, Van Harrison R, Passamani PP. Otitis media: diagnosis and treatment. Am Fam Physician 2013; 88(7): 435–40.
Gilsdorf JR. What the pediatrician should know about non-typeable Haemophilus influenzae. J Infect 2015; 1: S10–4. https://doi.org/10.1016/j.jinf.2015.04.014.
Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, et al. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 2001; 45: 1693–9. https://doi.org/10.1128/AAC.45.6.1693-1699.2001.
Skaare D, Lia A, Hannisdal A, Tveten Y, Matuschek E, Kahlmeter G, et al. Haemophilus influenzae with non-beta-lactamase-mediated beta-lactam resistance: easy to find but hard to categorize. J Clin Microbiol 2015; 11: 3589–95. https://doi.org/10.1128/JCM.01630-15.
Honda H, Sato T, Shinagawa M, Fukushima Y, Nakajima C, Suzuki Y, et al. Multiclonal expansion and high prevalence of β-lactamase-negative Haemophilus influenzae with high-level ampicillin resistance in Japan and susceptibility to quinolones. Antimicrob Agents Chemother 2018; 62(9): e00851–18. https://doi.org/10.1128/AAC.00851-18.
Lacross NC, Marrs CF, Patel M, Sandstedt SA, Gilsdorf JR. High genetic diversity of nontypeable Haemophilus influenzae isolates from two children attending a day care center. J Clin Microbiol 2008; 46: 3817–21. https://doi.org/10.1128/JCM.00940-08.